Emicizumab for acquired haemophilia A: A case series

Engelen, MM; Vandesande, J; De Bent, J; Van Laer, C; Labarque, V; Jacquemin, M; Peerlinck, K; Hermans, C; Verhamme, P; Vanassche, T

Engelen, MM (通讯作者),Univ Hosp Leuven, Hemophilia Ctr, Herestr 49, O&N1, Box 911, Leuven, Belgium.

HAEMOPHILIA, 2023; 29 (4): 1049

Abstract

BackgroundEmicizumab is approved to prevent bleeding in patients with congenital haemophilia A with or without inhibitors. However, no randomized tria......

Full Text Link